z-logo
open-access-imgOpen Access
Attention deficit hyperactivity disorder comorbidity in an adolescent diagnosed with L-2 hydroxyglutaric aciduria and response to atomoxetine treatment: a case report
Author(s) -
Çiğdem Yektaş,
Ali Evren Tufan
Publication year - 2016
Publication title -
dusunen adam the journal of psychiatry and neurological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 12
ISSN - 1018-8681
DOI - 10.5350/dajpn2016290309
Subject(s) - atomoxetine , attention deficit hyperactivity disorder , ataxia , medicine , comorbidity , pediatrics , psychiatry , epilepsy , methylphenidate , psychology
L-2-hydroxyglutaric aciduria (L-2 HGA) is a rare, neurodegenerative, slowly progressing and autosomal recessively inherited metabolic disorder. The disease progresses with mental retardation, behavioral disorder, ataxia, extrapyramidal signs and epileptic seizures. Diagnosis is made by detection of increased levels of L-2-hydroxyglutaric acid in urine, plasma or cerebrospinal fluid. In this report, we presented a 13 year old male patient diagnosed with L-2 HGA and had seizures, intellectual disability, attention deficit hyperactivity disorder (ADHD) symptoms and failure in school performance. Here we discussed this rare disease with ADHD symptoms and the response to atomoxetine treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom